Hydroxycobalamin is equally as effective as cyanocobalamin, and they share the cobalamin molecular structure
In January 2024, the FDA announced it was investigating semaglutide for several potential safety signals, including blood clots, alongside hair loss, aspiration risk, and suicidal ideation
was supported by an American Diabetes Association Womens Health Career Development Award (9-24-JDFWH-01), a MGH Physician-Scientist Development Award, and the National Institutes of Health COURAGE grant (U24 DK132733)
Targeted phenotypic characterization links genomic features to resistance profiles, stress responses, and environmental fitness
It forms acyl-carnitine esters with acyl-CoA derivatives, enabling entry into the mitochondrial matrix where -oxidation generates acetyl-CoA and ultimately ATP
Rat pancreatic and intestinal sections with an antiserum for human GLP-1 (737) (Phoenix Pharmaceuticals, Mountain View, California, USA) at a concentration of 1/500